Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer

Author(s): M. Frier

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 4 , Issue 1 , 2004

Become EABM
Become Reviewer
Call for Editor


The favourable nuclear properties of copper-67 and rhenium-188 for therapeutic application are described, together with methods for the chemical synthesis of a number of derivatives. Survival from invasive bladder cancer has changed little over the past 20 years. The intravesicular administration of Cu-67 or Re-188 radiopharmaceuticals in the treatment of bladder cancer offers some promise for improvement in this situation.

Keywords: Rhenium-188, Copper-67, Bladder, Cancer, Radioimmunotherapy

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2004
Published on: 01 March, 2012
Page: [61 - 68]
Pages: 8
DOI: 10.2174/1389557043487510

Article Metrics

PDF: 25